What one share of GRAIL holds
We are an innovative commercial-stage healthcare company focused on shifting the paradigm in early cancer detection at population scale. We believe screening individuals for many types of cancer with a single test represents a significant opportunity to reduce the global burden of cancer.
GRAIL’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $4.12 |
|---|---|
| Profit | −$9.76 |
| Capex (buildings and equipment) | $0.04 |
| Free cash flow | −$7.38 |
| Cash and investments | $1.25 |
| Book value | $56.93 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2022 | $1.79 | −$173.89 | $0.74 | −$18.81 | — | — |
| 2023 | $3.00 | −$47.21 | $0.42 | −$19.60 | — | — |
| 2024 | $3.94 | −$63.54 | $0.16 | −$18.26 | — | $73.86 |
| 2025 | $4.00 | −$11.11 | $0.02 | −$8.16 | — | $63.92 |
Common questions about GRAIL
How much does one share of GRAIL earn?
Over the last 12 months, GRAIL lost $9.76 for each share on $4.12 of sales.
Does GRAIL pay a dividend?
GRAIL didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is GRAIL’s book value per share?
GRAIL’s book value is $56.93 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of GRAIL have?
Each share of GRAIL has $1.25 of cash and investments, as of June 30, 2026.
What is GRAIL’s free cash flow per share?
−$7.38 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has GRAIL bought back shares?
GRAIL’s share count rose about 18% from 2022 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.